Introduction
Coxsackievirus and adenovirus receptor (CAR) has been identified as the primary receptor for subgroups A and C-F adenovirus (Ad) and group B coxsackievirus (CBV). [1] [2] [3] CAR is a type I transmembrane protein with two extracellular immunoglobulin (Ig) domains, and also belongs to the CTX subfamily of the Ig superfamily, which consists of proteins containing one V and one C2 Ig domain. [4] [5] [6] CAR has many physiological functions, such as formation of a tight junction in epithelial cells, [7] [8] [9] growth-inhibitory activity in tumor cells, 10, 11 and early embryonic cardiac development. 12, 13 One of the characteristics of members of the Ig superfamily is sequence homology among the members. 14 For example, CAR is structurally similar to CAR-like membrane protein (CLMP), 15 brain-and testis-specific Ig superfamily (BT-IgSF), 16 and endothelial cell-selective adhesion molecule (ESAM). 17 Another characteristic is that many of the Ig-superfamily genes produce soluble receptors that lack the transmembrane and cytoplasmic domains of full-length receptors. 18 Each of the soluble receptors is produced by proteolytic cleavage of the original membrane-bound receptor or de novo synthesis from alternatively spliced RNAs that are specific for the soluble receptor. 19 The soluble receptors are released from cells and appear in biological fluids or tissue culture supernatants. 20 They have been shown to play a significant role in various disorders, including viral infection. The soluble form of CAR is produced by alternative splicing in HeLa cells and shows inhibitory activity with regard to CVB infection. 21 It has been reported that soluble CAR in tumor effusions interferes with the Ad vector-mediated transduction in gene therapy. 22 However, much remains unknown regarding the physiological role of soluble receptors. In this study, we identified a novel protein, CAR-like soluble protein (CLSP), which is a soluble protein closely related to CAR. Mouse CLSP (mCLSP) has three IgV domains, each of which is homologous to the IgV domain of CAR. Overexpressed or recombinant mCLSP was found to inhibit the Ad vector-mediated transduction in CARexpressing cells, supporting the notion that CLSP may play a role in the antiviral defense of the host.
Results

Identification of CLSP
A search of the expressed sequence tag (EST) database for the nucleotide sequences of the N-terminal IgV domain of mouse CAR (mCAR) led to the identification of an EST sequence potentially encoding a CAR-like protein (GenBank accession number BB617533). To determine the full-length cDNA sequence, we carried out 5 0 -and 3 0 -RACE, as described in the Materials and methods. The full-length cDNA is 1567 bp in length and contains an open reading frame starting from the first methionine codon; it encodes a protein of 390 amino acids with a calculated molecular weight of 43 009 Da. The nucleotide sequence around the first methionine codon conforms well to the consensus sequence of the eukaryotic translational initiation site, and the 3 0 noncoding region contains a typical AATAAA polyadenylation signal. 23, 24 The deduced amino-acid sequence contains a highly hydrophobic N-terminal region characteristic of a signal peptide with a putative cleavage site between Ser-19 and Val-20. 25 Unlike CAR, this protein contains no transmembrane region. We performed a further search of the EST database, but could not identify the membrane-bound type of this protein. We therefore designated this protein as CLSP. mCLSP contained three IgV domains, IgV1, IgV2 and IgV3 (Figure 1a ). The three IgV domains were homologous and showed significant homology to the IgV (D1) domain of mCAR ( Figure 1b) . A search of the mouse genome database showed that the mCLSP gene is on chromosome 9, while mCAR is situated on the distal portion of chromosome 16. Therefore, mCLSP is not a splice variant of mCAR. Rat CLSP was found in the GenBank database (accession number BC063181) as a CAR-like protein having unknown functions, and showed an amino-acid homology of 85% to mCLSP.
Expression of CLSP mRNA in mouse tissues
We determined the expression of CLSP and CAR mRNA in various female mouse tissues by reverse transcription (RT)-PCR analysis (Figure 2 ). While the CAR mRNA was ubiquitously expressed in all examined tissues, the CLSP mRNA was found to be expressed at high levels in the brain and ovary, and at low levels in the lung, heart, kidney and uterus. The CLSP expression was also examined by Western blotting, but the expression was not observed in any tissues (data not shown). Therefore, it seems that CLSP is expressed at low levels in mice.
Inhibition of Ad vector infection by mCLSP
Ad binds to CAR via its N-terminal IgV domain. 26 Because the mCLSP protein contains three IgV domains, each of which shows significant homology to the N-terminal IgV domain of CAR, we examined whether mCLSP could affect the infection with Ad vector. SK HEP-1 cells, human hepatic endothelial cell lines, are The expression of mCLSP and mCAR mRNA in adult female mouse. Total RNA from each tissue was reverse-transcribed, and PCR was performed as described in the Materials and methods. The expression of glyceraldehyde 3-phosphate dehydrogenase (G3PDH) was used as a control. mCAR, mouse coxsackievirus and adenovirus receptor; mCLSP, mouse CAR-like soluble protein.
CAR-like soluble protein K Kawabata et al known to express high levels of CAR and are often used for experiments related to Ad vector infection. 27, 28 The mCLSP-expressing plasmid, pcDNA-mCLSP, was introduced into SK HEP-1 cells, and G418-resistant colonies were picked up, expanded and examined for the expression of mCLSP mRNA. Both wild-type SK HEP-1 cells and a transfected clone, SK HEP-1-mCLSP cells, highly expressed human CAR (hCAR), and only SK HEP-1-mCLSP cells showed high levels of mCLSP expression (Figure 3a) . These cells were infected with 100 VP/cell of luciferase-expressing Ad vector (Ad-L). As expected, the infection with Ad-L was significantly inhibited in SK HEP-1-mCLSP cells (Figure 3b) (Figure 4a) . However, the levels of inhibition caused by the mCLSPcontaining supernatant were fairly low. To determine why the inhibition was limited, flow cytometry analysis was performed to measure the amount of mCLSP on the cell surface. A substantial amount of mCLSP was found on the cell surface (Figure 4b ), suggesting that mCLSP is secreted from SK HEP-1-mCLSP cells and then binds to the cell surface by unknown mechanisms.
Recombinant mCLSP protects SK HEP-1 cells from Ad vector infection
We analyzed further whether mCLSP protein has an impact on viral infection when it is externally added to SK HEP-1 cells. For this purpose, mCLSP was bacterially expressed and purified as a NusA (Escherichia coli N-utilizing substance A)-mCLSP fusion protein ( Figure 5a ). 
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The major advantage of NusA, in addition to its good solubility characteristics, is its high expressivity. 32 Recombinant mCLSP was able to reduce moderately the infection with Ad vector in a dose-dependent manner when externally added to the culture medium of wildtype SK HEP-1 cells before and during Ad-L incubation ( Figure 5b ). The fusion protein formed of mCLSP and the adaptor protein NusA also slightly inhibited the infection with Ad-L. Thus, mCLSP indeed inhibits the infection with the Ad type 5.
Physical interaction of recombinant mCLSP with Ad
Because mCLSP contains three Ig domains, which show strong homology to the IgV domain of CAR, we hypothesized that mCLSP could bind to Ad. To test this hypothesis, we measured the binding activity between bacterially synthesized mCLSP and Ad by ELISA ( Figure 6 ). mCLSP, but not the NusA control protein, could bind to the Ad-coated plate. This result clearly shows that mCLSP can directly bind to Ad.
mCLSP promotes the infection with Ad vector in CAR-negative cells
Certain types of soluble receptors are known to promote viral infection in receptor-deficient cells. [33] [34] [35] For example, the soluble isoform of the herpes simplex virus (HSV) receptor, nectin1, promotes the infection of receptor-lacking cells with HSV. 35 We, therefore, wondered whether mCLSP might mediate the Ad vector infection of CAR-negative cells. NIH3T3 cells are known to be CAR-negative and resistant to Ad vector-mediated transduction. 36 pcDNA-mCLSP was introduced into NIH3T3 cells, and G418-resistant colonies were isolated, cultured and examined for the expression of mCLSP mRNA. In comparison with the wild-type NIH3T3 cells, cells of the transfected clone NIH3T3-mCLSP showed a high expression of mCLSP (Figure 7a ). After infection with Ad-L, NIH3T3-mCLSP cells showed higher levels of luciferase expression than wild-type NIH3T3 cells (Figure 7b) , and the amount of Ad DNA was also increased in NIH3T3-mCLSP cells (Figure 7c ). These results suggest that mCLSP can support the infection of receptor-deficient cells with Ad vector.
Evolutionary origin of the mCLSP gene CAR belongs to the CTX family in the Ig superfamily. 15 We constructed a phylogenetic tree using amino-acid sequences of several vertebrate IgV domains in the CTX family. The results revealed that the closest relative to CLSP is CAR, followed by CLMP, 15 BT-IgSF 16 and ESAM.
17 Figure 8a shows a phylogenetic tree of the IgV domains of CAR and CLMP for the mouse, rat, human, bovine and chicken and three IgV domains of CLSP for the mouse and rat. The tree suggests that the segmental duplication including the first three exons of CAR occurred before the divergence of rodents and other mammals. Following the first duplication, the number of CLSP IgV domains increased before the divergence of the mouse and rat by two segmental duplication events, which harbored exons 2 and 3 of CLSP.
The gene encoding mCLSP was identified on the mouse chromosome 9E3.3 (Figure 8b ). The phylogenetic tree indicates that rodent CLSP genes branched off before the Primates-Carnivoa-Rodentia divergence and were lost in the descendants except for the rodent lineage. We thoroughly examined syntenic regions of the human and bovine genome sequences and found that the human and bovine genomes completely lacked CLSP genes ( Figure 8 ). The results indicated that the CLSP gene was convergently lost in mammals except for those of the rodent lineage, where the further segmental duplications of IgV domains occurred.
Discussion
In this study, we identified a novel CTX family protein, CLSP, which is related to CAR in terms of structure and function. The inclusion of CLSP in the CTX family in the Ig superfamily is based on studies of the structure of CLSP and its phylogenetic relationship with other CTX family proteins. The most distinctive feature of CLSP is that this protein lacks a transmembrane domain. The CAR-like soluble protein K Kawabata et al membrane-type of CLSP was not found either by a search of the EST database or by a 3 0 -RACE using the reverse-transcribed cDNA from the brain, kidney and ovary (data not shown). Therefore, we reached the conclusion that CLSP exists primarily as a soluble protein.
While CAR mRNA was ubiquitously expressed in many tissues, CLSP mRNA was expressed only in limited tissues in mice. CLSP mRNA was highly expressed in the brain and ovary, although CLSP protein expression was not detected in any organs. CLSP mRNA expression might be involved in several important functions, such as resistance to viral infection. Some members of the Ig superfamily have alternative splicing variants. For example, CAR has three variants that lack a transmembrane domain and are produced by alternative splicing events between exons IV and VII, exons III and VII, and exons II and VII. 21 Interestingly, these soluble forms of CAR have been found to inhibit CVB3 and Ad infection. 21, 22 Because the Ad binds to the N-terminal IgV domain of CAR 26 and CLSP shows homology to its domain, we examined the effects of CLSP on Ad vector infection. As a result of the infection of CLSP-expressing SK HEP-1 cells with Ad vector, CLSP showed efficient inhibition of the Ad vector-mediated reporter gene expression. The culture supernatant of CLSP-expressing cells also inhibited Ad vector-mediated gene expression. ELISA experiments showed that CLSP could directly associate with Ad, suggesting that CLSP may compete with CAR for Ad fiber. As CLSP contains three IgV domains, it would be necessary to determine which domains bind to Ad. Bacterially synthesized recombinant CLSP could also inhibit the infection with Ad vectors, suggesting that CLSP competes with the IgV domain of CAR for Ad. However, the recombinant CLSP, which was collected from the supernatant of SK HEP-1 cells stably expressing mCLSP (SK HEP-1-mCLSP cells), showed only slight inhibition of Ad vector infection in comparison with the supernatant of wild-type SK HEP-1 cells. Flow cytometry analysis in SK HEP-1-mCLSP cells revealed that mCLSP was found on the cell surface. This is why the level of inhibition achieved by the addition of the mCLSP-containing supernatant was fairly low. Further investigations are needed to clarify the binding mechanism.
HSV is known to infect cells via nectin1, which is a member of the Ig superfamily. 37 It has been reported that CAR-like soluble protein K Kawabata et al the soluble isoform of nectin1 positively and negatively modulates susceptibility to HSV infection. 35 The soluble nectin1 reduced HSV infectivity by competing with membrane-bound nectin1. On the other hand, forced expression of the soluble form of nectin1 cDNA in cells lacking membrane-bound nectin1 enabled HSV to enter the cells. 35 In this study, we showed that mCLSP inhibits the infectivity of Ad vectors to CAR-positive cells, while mCLSP promotes the entry of Ad vectors into CARnegative cells. Although the exact mechanisms responsible for this difference remain unknown, this finding raises the possibility that mCLSP localizes to the plasma membrane to enable the entry of Ad vectors into CARnegative cells. After Ad vector binds to CLSP in the plasma membrane, the Ad-CLSP complex might enter the cells in some fashion, such as via endocytosis, with low efficiency in the case of CAR-negative cells. On the other hand, in the case of CAR-positive cells, the formation of Ad-CAR complex would be inhibited by CLSP. Since the efficiency of entry of the Ad-CLSP complex into cells would be much lower than that of the Ad-CAR complex, CLSP negatively modulates susceptibility to Ad infection in CAR-positive cells, and positively modulates it in CAR-negative cells. Thus, it would be of interest to investigate how CLSP interacts with CAR.
Chromosome analysis suggests that the CLSP gene is rodent-specific, and that human and bovine lack this gene. The phylogenetic tree, however, indicates that rodent CLSP genes branched off before the radiation of mammals and were lost in all descendants except for those of the rodent lineage. Interestingly, the segmental duplications that tripled the IgV domain occurred after the first gene duplication, which duplication may increase the diversity of affinity to viruses. In future studies, the physiological function of CLSP will be further clarified by constructing and analyzing CLSPdeficient mice. CLSP, which is a soluble protein and the closest relative to CAR, may have antiviral potential in rodent animals.
Materials and methods
Molecular cloning of mCLSP
BLAST analysis of the mouse EST cDNA library with the sequence of the full-length mCAR cDNA led to identification of a cDNA fragment that is homologous to but different from mCAR. The EST accession number is BB617533. Total RNA was purified from 8 weeks of age of mouse ovary, and 5 0 -and 3 0 -RACE (rapid amplification of cDNA ends) was performed using a SMART RACE cDNA Amplification Kit (Clontech, Palo Alto, CA, USA) to obtain the full-lengh cDNA of clone BB617533. The full-length cDNA was sequenced and designated as CLSP (GenBank accession number AB262662).
RT-PCR
Each tissue from adult female mouse was excised. Total RNA was extracted with ISOGEN (Wako, Osaka, Japan) and was reverse-transcribed using the SuperScript First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). Synthesized cDNA was amplified by PCR using Ex Taq DNA Polymerase (Takara, Shiga, Japan). The sequences of the specific primers were as
0 . The cycle conditions were 30 s at 941C, followed by 30 cycles of 5 s at 941C, 10 s at 601C, and 1 min at 721C and a final extension of 7 min at 721C.
Transfection
The coding sequence of mCLSP was amplified by PCR with Ex Taq DNA Polymerase and cloned into pGEM-T Easy Vector (Promega, Madison, WI, USA). The cDNA was sequenced and cloned into the EcoRI site of the mammalian expression vector, pcDNA3 (Invitrogen), generating pcDNA-mCLSP. SK HEP-1 cells 27 and NIH3T3 mouse fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum, and were transfected with pcDNA-mCLSP using SuperFect Transfection Reagent (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. For stable transfection, SK HEP-1 cells or NIH3T3 cells transfected with pcDNA-mCLSP were cultured for 10 days in DMEM containing 100 mg/ml G418 (Invitrogen). G418-resistant colonies were picked up, expanded, and used for further analysis.
Recombinant CLSP expression and purification
The pET43b-mCLSP plasmid was generated by inserting a PCR fragment, encoding mCLSP, into the SacI-XhoI sites of pET43.1b(+) (Novagen, San Diego, CA, USA). The vector and insert sequence at the junctions was confirmed by sequencing. The pET43b-mCLSP-transformed Rosetta-gami B (DE3) cells (Novagen) were cultured with 0.5 mM IPTG at 251C for 18 h. The cell pellet was resuspended in lysis buffer (20 mM Tris-HCl, 0.5 M NaCl, 5 mM imidazole, 0.1% Triton X-100, pH 7.9) mixed with 0.1 mg/ml of lysozyme (Wako) and incubated at 301C for 15 min. The lysate was sonicated and centrifuged at 10 000 g for at 41C for 20 min, and filtered with 0.45 mm filter. We chose NusA as a highly favorable solubility partner of mCLSP. The fusion protein NusAmCLSP was purified with His-Bind resin (Novagen) by following the manufacturer's instructions, with slight modifications. Briefly, the lysate was loaded onto a Ni-NTA column before the purification of the fusion protein to remove free-NusA protein. The flow-through fraction containing fusion protein was collected and employed for purification. After the solvent was changed to phosphate-buffered saline (PBS) by dialysis, fusion protein NusA-mCLSP was digested by biotinylatedthrombin at 201C for 2 h, and then biotinylated-thrombin was removed using streptavidin-agarose (Novagen). The purified protein was dialyzed in PBS, and the protein content was determined with the protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin as a standard.
Western blotting
A rabbit polyclonal antibody for mCLSP was prepared using peptide (FYQDMKGRVQFTSNDIR). E. coli lysate and each recombinant protein (2 mg) were mixed with the same amount of 2 Â sodium dodecyl sulfate (SDS) CAR-like soluble protein K Kawabata et al loading buffer. The samples were incubated at 951C for 5 min, and they were loaded onto the 12.5% SDS-polyacrylamide gels. Proteins were separated at 20 mA and then blotted to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA) in Tris-glycine transfer buffer at 100 V for 2 h. The membrane was blocked with 3% skim milk in TBST (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% Tween20) at room temperature for 2 h. Polyclonal antibody against mCLSP (diluted with blocking solution to 1:2000) was added and incubated at 3 h, and the membrane was then incubated with anti-rabbit IgG horseradish peroxidase (HRP) conjugated secondary antibody (Cell Signaling Technology, Danvers, MA, USA) for 1 h. The band was visualized by Chemi-Lumi One (Nacalai Tesque, Kyoto, Japan). The signals were read using a LAS-3000 Image Analyzer (FUJIFILM, Tokyo, Japan).
Effects of CLSP on Ad vector infection
The luciferase-expressing conventional Ad vector (Ad-L), based on Ad type 5, and type 35 Ad vector (Ad35-L) had been generated previously. 27, 38 Ad-L is identical to Ad-L2. 27 Both vectors contain the cytomegalovirus promoter-driven luciferase expression cassette in the E1 deletion region. SK HEP-1-mCLSP cells, which are SK HEP-1 cells stably expressing mCLSP, were infected with 100 virus particles (VP)/cell of Ad-L or Ad35-L at 371C for 1.5 h. Cells were washed with PBS and further cultured. After 24 h, luciferase activity in SK HEP-1 cells was measured using a luciferase assay system Pica Gene LT2.0 (Toyo Inki, Tokyo, Japan).
27 NIH3T3-mCLSP cells, which are NIH3T3 cells stably expressing mCLSP, were infected with 300 VP/cell of Ad-L, and the luciferase activity was measured as described above. The Ad genome DNA in the cells was quantified with a TaqMan fluorogenic detection system (ABI PRISM 7700 sequence detector; Applied Biosystems, Foster City, CA, USA). Sample DNA was isolated with an automatic nucleic acid isolation system (NA-2000; Kurabo Industries, Osaka, Japan). Primers for amplification were located in the E4 region, with the sequences CACCACCTCCCGGTACC ATA (sense) and CCGCACCTGGTTTTGCTT (antisense). The fl detection probe had the sequence AACCTGCC CGCCGGCTATACACTG. Samples were amplified for 40 cycles in the ABI PRISM 7700 sequence detector with continuous fluorescence monitoring. Data were processed with ABI PRISM 7000 SD software (Applied Biosystems). For the inhibition assay with the recombinant mCLSP protein, the culture supernatant from SK HEP-1 cells, SK HEP-1-mCLSP cells or the bacterially synthesized mCLSP protein was added to the medium of wild-type SK HEP-1 cells. The cells were then infected with 100 VP/cell of Ad-L or Ad35-L, and the luciferase activity was measured as described above.
Flow cytometry analysis
SK HEP-1 and SK HEP-1-mCLSP cells were reacted with rabbit anti-mCLSP antibody and stained with fluorescein isothiocyanate-labeled goat anti-rabbit IgG. The cells were analyzed by using FACSCalibur and CellQuest software (BD Biosciences, Tokyo, Japan).
ELISA
Ad-L (1 Â 10 9 VP) was coated on a 96-well plate by incubation at 41C for 24 h. Bacterially synthesized NusA or thrombin-digested NusA-mCLSP was added to the plate at the indicated concentrations. The plate was incubated at room temperature for 2 h, washed with PBS and reacted with anti-mCLSP antibodies followed by biotin-conjugated anti-rabbit IgG. Binding was detected with streptavidin-conjugated HRP.
Computational analysis
The amino-acid sequences of CAR group IgV domains were aligned with Clustal W. 39 The Neighbor-Joining tree was constructed using the protein-Poisson distances, 40 and bootstrap percentile values were shown at each node (1000 replications). The amino-acid sequences were obtained from Genbank (mCAR, NP_001020363; rat CAR, NP_446022; hCAR, NP_001329; bovine CAR, NP_776723; chicken CAR, XP_416681; mouse CLMP, NP_598494; rat CLMP, NP_775177; human CLMP, NP_079045; bovine CLMP, XP_617487; chicken CLMP, XP_417886). The alignment and tree construction were performed using the MEGA 3.0 program package. 41 For genomic assignment of the CLSP locus, the mouse, rat, human and bovine genome sequences were examined using the UCSC genome browser (http://genome.ucsc. edu/).
